Atea Pharmaceuticals Share Price (NASDAQ: AVIR)
$3.37
Last updated on
Check the interactive Atea Pharmaceuticals Stock chart to analyse performance
Atea Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.35Today's High:$3.48
0.74%
Downside
Day's Volatility :3.88%
Upside
3.16%
- 52 Weeks Low:$2.4652 Weeks High:$4.15
27.15%
Downside
52 Weeks Volatility :40.77%
Upside
18.7%
Atea Pharmaceuticals Stock Returns
Atea Pharmaceuticals Inc Key Stats
Check Atea Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Atea Pharmaceuticals Stock including INR - Dollar returns
The Atea Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atea Pharmaceuticals investment value today
Current value as on today
₹98,122
Returns
Returns from Atea Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Atea Pharmaceuticals Stock
Global Institutional Holdings in Atea Pharmaceuticals Inc
Name
Holdings %
BlackRock Inc
11.02%
BML Capital Management LLC
9.38%
FMR Inc
7.42%
TANG CAPITAL MANAGEMENT LLC
6.03%
Vanguard Group Inc
6.02%
Bain Capital Life Sciences Investors, LLC
3.06%
Analyst Recommendation on Atea Pharmaceuticals Stock
Sell
11%Buy
33%Hold
55%Sell
Based on 9 Wall street analysts offering stock ratings for Atea Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Atea Pharmaceuticals Share Price Target
What analysts predicted
Upside of 122.55%
Target:
$7.50
Current:
$3.37
Atea Pharmaceuticals share price target is $7.50, a slight Upside of 122.55% compared to current price of $3.37 as per analysts' prediction.
Atea Pharmaceuticals Stock Insights
Price Movement
In the last 7 days, AVIR stock has moved down by -8.2%AVIR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 82.6%AVIR vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 168.4%Price to Sales
ForAVIR every $1 of sales, investors are willing to pay $1.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Atea Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Atea Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Atea Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -7.69% | 15.86% | -7.44% | -54.9% | -88.93% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 11.84 | NA | NA | -1.63 | -0.32 | -0.2 | NA | 4.49 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $275.4M | -88.93% | 11.84 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Atea Pharmaceuticals Inc
Key Management of Atea Pharmaceuticals Inc
Important FAQs about investing in AVIR Stock from India :
What is Atea Pharmaceuticals share price today?
Atea Pharmaceuticals share price today is $3.37 as on at the close of the market. Atea Pharmaceuticals share today touched a day high of $3.48 and a low of $3.35.
What is the 52 week high and 52 week low for Atea Pharmaceuticals share?
Atea Pharmaceuticals share touched a 52 week high of $4.15 and a 52 week low of $2.46. Atea Pharmaceuticals stock price today i.e. is closed at $3.37, lower by 18.7% versus the 52 week high.
How to invest in Atea Pharmaceuticals Stock (AVIR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Atea Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atea Pharmaceuticals Shares that will get you 0.4451 shares as per Atea Pharmaceuticals share price of $3.37 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Atea Pharmaceuticals Stock (AVIR) from India?
Indian investors can start investing in Atea Pharmaceuticals (AVIR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Atea Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Atea Pharmaceuticals share’s latest price of $3.37 as on August 30, 2025 at 1:29 am IST, you will get 2.9674 shares of Atea Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Atea Pharmaceuticals has given to Indian investors in the last 5 years?
Atea Pharmaceuticals stock has given -88.93% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%